D335

Tumorvirus-spez. Vakzinierungsstrategie
IDI:(DE-He78)D335-20160331

Recent Publications

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS | 

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;
Assessment of Mycobacterium tuberculosis dodecin scaffold as a multimerization platform on the immunogenicity of HPV L2 antigens.
Scientific reports 16(1), 9086 () [10.1038/s41598-026-42678-7]  GO OpenAccess  Download fulltext Files BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Factors impacting protective immunity conferred by vaccination with adeno-associated virus-like particles displaying human papillomavirus L2 residues 17-36.
Journal of virology 100(9), e0044826 () [10.1128/jvi.00448-26]  GO DBCoverage BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
In Silico Design and Subsequent Expression of Human Papillomavirus-16 and -18 L1 Vaccine Antigens in Broccoli.
Vaccines 14(3), 261 () [10.3390/vaccines14030261]  GO OpenAccess  Download fulltext Files  Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Protective Human Papillomavirus Type 16/18 Vaccine-Induced Neutralizing Antibody Levels Remain Elusive.
Open Forum Infectious Diseases 13(4), ofag174 () [10.1093/ofid/ofag174]  GO OpenAccess  Download fulltext Files  Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Real-time genome imaging of host interactions in adeno-associated virus genome release
iScience 28(6), 112624 () [10.1016/j.isci.2025.112624]  GO DBCoverage BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article (Editorial)  ;  ;
Editorial: Papillomaviruses, immunity, and tumour development.
Frontiers in Cellular and Infection Microbiology 15, 1599910 () [10.3389/fcimb.2025.1599910]  GO DBCoverage   Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;
Die Entwicklung eines neuen Impfstoffs gegen humane Papillomviren (HPV) im akademischen Umfeld – TEIL 2 / Papillomavirus Impfstoff PANHPVAX:First-in-Human – eine neue Herausforderung
PM/QM - Fachzeitschrift für pharmazeutische Medizin und Qualitätsmanagement - nur für Mitglieder 1, 46-54 ()  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article (Review Article)  ;  ;  ;  ;  ;  ;
Scientific approaches to defining HPV vaccine-induced protective immunity.
International journal of cancer 156(10), 1848-1857 () [10.1002/ijc.35345]  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;
Mechanistic insights into HPV-positivity in non-smokers and HPV-negativity in smokers with head and neck cancer.
Frontiers in oncology 14, 1484319 () [10.3389/fonc.2024.1484319]  GO OpenAccess  Download fulltext Files  Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;
Die Entwicklung eines neuen Impfstoffs gegen humane Papillomviren (HPV) im akademischen Umfeld – TEIL 1 Papillomavirus Impfstoff PANHPVAX: Herausfordernde Schritte von der Idee zur Erstanwendungsstudie
PM/QM - Fachzeitschrift für pharmazeutische Medizin und Qualitätsmanagement - nur für Mitglieder 26(3), 4-11 ()  GO BibTeX | EndNote: XML, Text | RIS

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS | 


 Record created 2024-02-14, last modified 2024-02-15



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)